Toxicity of thiopurines in patients with inflammatory bowel disease: Frequency and risk factors

被引:0
|
作者
Ben Mustapha, N. [1 ]
Labidi, A. [1 ]
Serghini, M. [1 ]
Fekih, M. [1 ]
Boubaker, J. [1 ]
Filali, A. [1 ]
机构
[1] La Rabta Hosp, Gastroenterol A, Tunis, Tunisia
来源
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词
D O I
10.1016/S1873-9946(14)60431-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P310
引用
收藏
页码:S194 / S194
页数:1
相关论文
共 50 条
  • [21] Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
    Peyrin-Biroulet, Laurent
    Khosrotehrani, Kiarash
    Carrat, Fabrice
    Bouvier, Anne-Marie
    Chevaux, Jean-Baptiste
    Simon, Tabassome
    Carbonnel, Frank
    Colombel, Jean-Frederic
    Dupas, Jean-Louis
    Godeberge, Philippe
    Hugot, Jean-Pierre
    Lemann, Marc
    Nahon, Stephane
    Sabate, Jean-Marc
    Tucat, Gilbert
    Beaugerie, Laurent
    GASTROENTEROLOGY, 2011, 141 (05) : 1621 - U150
  • [22] OSTEOPOROSIS RISK FACTORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Nassar, K.
    Janani, S.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S148 - S149
  • [23] Thrombophilic Risk Factors in Patients With Inflammatory Bowel Disease
    Yazici, Ayten
    Senturk, Omer
    Aygun, Cem
    Celebi, Altay
    Caglayan, Cigdem
    Hulagu, Sadettin
    GASTROENTEROLOGY RESEARCH, 2010, 3 (03) : 112 - 119
  • [24] Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased
    van Schaik, Fiona D. M.
    van Oijen, Martijn G. H.
    Smeets, Hugo M.
    van der Heijden, Geert J. M. G.
    Siersema, Peter D.
    Oldenburg, Bas
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 449 - 450
  • [25] The Evolving Role of Thiopurines for Inflammatory Bowel Disease
    Rosen, Danya J.
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (01) : 234 - 240
  • [26] Optimising use of thiopurines in inflammatory bowel disease
    Raj, Lawrence Sunder
    Hawthorne, A. Barney
    FRONTLINE GASTROENTEROLOGY, 2010, 1 (01) : 44 - 51
  • [27] Optimizing the use of thiopurines in inflammatory bowel disease
    Goel, Rishi M.
    Blaker, Paul
    Mentzer, Alex
    Fong, Steven C. M.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 138 - 146
  • [28] Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases
    Kakuta, Yoichi
    Iwaki, Hideya
    Umeno, Junji
    Kawai, Yosuke
    Kawahara, Masahiro
    Takagawa, Tetsuya
    Shimoyama, Yusuke
    Naito, Takeo
    Moroi, Rintaro
    Kuroha, Masatake
    Shiga, Hisashi
    Watanabe, Kenji
    Nakamura, Shiro
    Nakase, Hiroshi
    Sasaki, Makoto
    Hanai, Hiroyuki
    Fuyuno, Yuta
    Hirano, Atsushi
    Matsumoto, Takayuki
    Kudo, Hisaaki
    Minegishi, Naoko
    Nakamura, Minoru
    Hisamatsu, Tadakazu
    Andoh, Akira
    Nagasaki, Masao
    Tokunaga, Katsushi
    Kinouchi, Yoshitaka
    Masamune, Atsushi
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (04): : 643 - 655
  • [29] Use of thiopurines in inflammatory bowel disease: an update
    Singh, Arshdeep
    Mahajan, Ramit
    Kedia, Saurabh
    Dutta, Amit Kumar
    Anand, Abhinav
    Bernstein, Charles N.
    Desai, Devendra
    Pai, C. Ganesh
    Makharia, Govind
    Tevethia, Harsh Vardhan
    Mak, Joyce W. Y.
    Kaur, Kirandeep
    Peddi, Kiran
    Ranjan, Mukesh Kumar
    Arkkila, Perttu
    Kochhar, Rakesh
    Banerjee, Rupa
    Sinha, Saroj Kant
    Ng, Siew Chien
    Hanauer, Stephen
    Verma, Suhang
    Dutta, Usha
    Midha, Vandana
    Mehta, Varun
    Ahuja, Vineet
    Sood, Ajit
    INTESTINAL RESEARCH, 2022, 20 (01) : 11 - 30
  • [30] Optimising use of thiopurines in inflammatory bowel disease
    Dart, Robin J.
    Irving, Peter M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (09) : 877 - 888